Yowei Therapeutics and Yowei Oncology are stealth stage life sciences companies working closely with CSBio to advance peptide based clinical programs. Their work spans longevity and peptide therapeutics, clinical trials, evaluation of a 503A pharmacy model, patient specific neoantigen peptide oncology programs, and supporting microbiology and laboratory capabilities. Together, they are building the clinical, pharmacy, data, laboratory, and operational infrastructure needed to responsibly translate peptide programs into patient facing studies and services. Both companies expect to remain in stealth till Q1 2027.
CSBio is a leading peptide and peptide synthesizer manufacturing company located on the edge of Silicon Valley in Menlo Park, California. Since 1993, CSBio has been providing high quality custom peptides, cGMP peptides and automated peptide synthesizers to the global biotech community. CSBio peptide products and peptide synthesis equipment can be found in peptide production laboratories and pharmaceutical companies worldwide.
CSBio state of the art cGMP manufacturing facility provides cGMP peptides for preclinical and clinical programs and our commercialization and regulatory teams can take you from toxicology studies through market commercialization. CSBio has recently received a Recommendation For Approval from the USFDA following an extensive USFDA PAI audit.
CSBio’s product line also includes a complete list of generic peptide APIs including the most widely used peptide APIs in the industry. CSBio now also offers solid phase peptide synthesis resins as well as high quality Fmoc and Boc protected amino acids for use in both R&D and cGMP peptide manufacturing.
> Powered by Workable. ## Open Positions - All open roles (GET `https://apply.workable.com/yowei/jobs.md`): 15 current openings - Other: 15 roles ## Optional - [Careers page](https://apply.workable.com/yowei/): Main careers page - [Company website](http://yoweitherapeutics.com): Yowei Therapeutics website